Search

everythinglearnresearchcommunity

for

Search:↓

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

UV radiation causes skin cancer, but sunscreens and certain drugs can help prevent it.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Erdr1 could be a new marker for diagnosing hair loss.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

FOXO1 is important for wound healing, but its dysfunction in diabetes can slow the healing process.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.